In reply

Affiliations

¹ School of Medicine and Public Health, University of Newcastle and Department of Clinical Toxicology, Calvary Mater Newcastle, New South Wales, Australia.
² New South Wales Poisons Information Centre, Sydney Children's Hospital Network, New South Wales, Australia; Clinical Pharmacology, Sydney Medical School, University of Sydney, New South Wales, Australia.
³ Centre for Clinical Research in Emergency Medicine, Royal Perth Hospital, Harry Perkins Institute of Medical Research and the University of Western Australia, Perth, Australia.

Comment

Geoffrey K Isbister et al. Ann Emerg Med. 2015 Jan.

. 2015 Jan;65(1):124-5.

doi: 10.1016/j.annemergmed.2014.08.021.

¹ School of Medicine and Public Health, University of Newcastle and Department of Clinical Toxicology, Calvary Mater Newcastle, New South Wales, Australia.
² New South Wales Poisons Information Centre, Sydney Children's Hospital Network, New South Wales, Australia; Clinical Pharmacology, Sydney Medical School, University of Sydney, New South Wales, Australia.
³ Centre for Clinical Research in Emergency Medicine, Royal Perth Hospital, Harry Perkins Institute of Medical Research and the University of Western Australia, Perth, Australia.

No abstract available

Comment on

Randomized controlled trial of intravenous antivenom versus placebo for latrodectism: the second Redback Antivenom Evaluation (RAVE-II) study.
Isbister GK, Page CB, Buckley NA, Fatovich DM, Pascu O, MacDonald SP, Calver LA, Brown SG; RAVE Investigators. Isbister GK, et al. Ann Emerg Med. 2014 Dec;64(6):620-8.e2. doi: 10.1016/j.annemergmed.2014.06.006. Epub 2014 Jul 3. Ann Emerg Med. 2014. PMID: 24999282 Clinical Trial.
Latrodectism and effectiveness of antivenom.
White J, Weinstein SA. White J, et al. Ann Emerg Med. 2015 Jan;65(1):123-4. doi: 10.1016/j.annemergmed.2014.08.022. Ann Emerg Med. 2015. PMID: 25529159 No abstract available.